2005

1. Krszyna K, Stokłosa T. Czynnik indukowany przez hipoksję-1 (HIF-1): Budowa, regulacja ekspresji, funkcja oraz rola w progresji nowotworów. Post Biol Kom. 2005; 32(4): 707-728

2. Nowis D, Stokłosa T, Legat M, Issat T, Jakóbisiak M, Gołąb J. The influence of PDT on the immune response. Photodiagn. Photodyn. Ther. 2005; 2:283-298

3. Ciechomska I, Legat M, Golab J, Wesolowska A, Kurzaj Z, Mackiewicz A, Kaminska B. Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies. Int J Cancer. 2005 Oct 20;117(1):59-67

4. Stoklosa T, Golab J. Prospects for p53-based cancer therapy. Acta Biochim Pol. 2005;52(2):321-8. Epub 2005 Jun 25

5. Nowis D, Makowski M, Stoklosa T, Legat M, Issat T, Golab J. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol. 2005;52(2):339-52


6. Wang J-Y, Ho T, Trojanek J, Chintapalli J, Grabacka M, Stoklosa T, Garcia F-U, Skorski T, Reiss K. Impaired homologous recombination DNA repair and enhanced sensitivity to DNA damage in prostate cancer cells exposed to anchorage-independence. Oncogene 2005 May 26;24(23):3748-58

7. Adamek M, Krawczyk-Krupka A, Mostowy A, Czuba Z, Król W, Kasperczyk S, Jakóbisiak M, Gołąb J, Sieroń A. Topical ALA-PDT modifies neutrophils' chemiluminescence, lymphocytes' interleukin-1 beta secretion and serum level of transforming growth factor beta 1 in patients with non melanoma skin malignancies. A clinical study. Photodiagn. Photodyn. Ther. 2005 (in press)

8. Gołąb J, Stokłosa T, Technology evaluation: SB-485232. Curr. Opin. Mol. Ther. 2005; 7(1):85-93